Majycc Innovation Santé
VC Fund
Paris, France
Majycc Innovation Santé is a VC fund in Paris focused on Health Care and Medical Device. Majycc eSanté Invest is an investment firm
- Total investments:
- 9
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Majycc Innovation Santé invests in
Stages Majycc Innovation Santé invests in
Countries Majycc Innovation Santé invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $1.5M–$4.8M
- Series A
- $6.1M–$18M
Investment Focus
Industry
- Health Care 3 (33%)
- Medical Device 3 (33%)
- Software 2 (22%)
- Artificial Intelligence 2 (22%)
- Fitness 1 (11%)
Stage
- Seed 3 (33%)
- Series A 3 (33%)
- Funding Round 2 (22%)
- Series B 1 (11%)
Country
- France 7 (78%)
- Belgium 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CEO | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sunrise
|
Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems. | $29.2M / Sep 25, 2025 | |
|
Brightflow
|
Brightflow operates as a medical device startup. | $18.2M / Series A / Sep 10, 2024 | |
Archeon
|
Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and treatment of critically ill patients in prehospital care. | $6.1M / Series A / Mar 16, 2022 | |
NaoX Technologies
|
NaoX Technologies is a connected solution for the prevention of neurological disorders. They develop wireless headphones that listen to brain vibrations. Their objective is to democratize neurological disorder prevention. The embedded sensors in the company's earphones passively record the electroencephalogram in by detecting brain vibrationsand aggregating data on the software dashboard for the attending physician. | $4.7M / Jan 27, 2022 | |
|
NaoX Technologies
|
NaoX Technologies is a connected solution for the prevention of neurological disorders. They develop wireless headphones that listen to brain vibrations. Their objective is to democratize neurological disorder prevention. The embedded sensors in the company's earphones passively record the electroencephalogram in by detecting brain vibrationsand aggregating data on the software dashboard for the attending physician. | $4.8M / Seed / Jan 27, 2022 | |
i-Virtual
|
i-Virtual develops software which allows physiological & emotional values to be measured using the camera of a smartphone or computer. | $3M / Seed / Mar 09, 2021 | |
Gleamer
|
Gleamer develops an AI-powered software to enhance radiologists’ productivity. | $8.8M / Series A / Sep 24, 2020 | |
Epigene Labs
|
Over the past couple of decades, the exponential progress of sequencing technologies has allowed an increasing number of cancer patients to benefit from precision oncology. However, the aggregation, analysis, and visualization of the massive amounts of genomic data remain a major challenge for precision oncology expansion.The Epigene Labstechnology platform enables cancer drug hunters to seamlessly leverage advanced artificial intelligence in transforming genomic data into actionable insights for designing precision oncology approaches.With R&D in Paris and business development in Boston, Epigene Labs operates in the setting of value-based partnerships with world leading cancer centers and high-profile biotechs. | $1.5M / Seed / Jan 30, 2020 | |
Lifen
|
Lifen is a 160-person startup, based in Paris, whose ambition is to facilitate the deployment of digital solutions for hospitals, doctors and patients. Since 2015, Lifen has been simplifying the sharing of medical data and has quickly established itself as the leading MSSanté operator in France with more than 600 partner establishments. Everymonth, Lifen sends 2 million medical documents to 240,000 doctors. Creator of the FHIR France meetup and winner of the ANS interoperability prize 2020, Lifen's ambition is to use its expertise in interoperability with HIS to develop a platform that radically simplifies the technical integration and operational deployment of all types of digital solutions. | $22.7M / Series B / Jun 13, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Majycc Innovation Santé invest in?
Majycc Innovation Santé invests primarily in Health Care, Medical Device and Software startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Majycc Innovation Santé's check size?
Majycc Innovation Santé typically joins rounds of $1.5M–$4.8M at Seed and $6.1M–$18M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Majycc Innovation Santé participates in.
How do I contact Majycc Innovation Santé?
Public channels for Majycc Innovation Santé include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Majycc Innovation Santé?
The team at Majycc Innovation Santé includes Pauline de Breteuil (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
